BIO’s New CEO Is Biotech Industry Veteran With Compelling Family Story, Ready To Take On The IRA

John Crowley will take the reins at BIO in March, about a year and a half after the departure of former CEO Michelle McMurry-Heath was announced.

Crowley Is Long-Time BIO Board Member, 'Steeped' In Issues • Source: Shutterstock

The Biotechnology Innovation Organization’s new president and CEO John Crowley brings to the role more than two decades of experience in the biotech drug industry and a strong history of rare disease patient advocacy, both driven by his experience as the father of two children with the genetic neuromuscular disorder Pompe disease.

His background and personal story positions Crowley as an effective advocate for the biotech industry at a time when the...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Legislation

More from Pink Sheet